These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23267077)

  • 1. Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease.
    Fitzmaurice AG; Rhodes SL; Lulla A; Murphy NP; Lam HA; O'Donnell KC; Barnhill L; Casida JE; Cockburn M; Sagasti A; Stahl MC; Maidment NT; Ritz B; Bronstein JM
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):636-41. PubMed ID: 23267077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease.
    Casida JE; Ford B; Jinsmaa Y; Sullivan P; Cooney A; Goldstein DS
    Chem Res Toxicol; 2014 Aug; 27(8):1359-61. PubMed ID: 25045800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.
    Goldstein DS; Sullivan P; Cooney A; Jinsmaa Y; Kopin IJ; Sharabi Y
    J Neurochem; 2015 Apr; 133(1):14-25. PubMed ID: 25645689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism for benomyl action as a mitochondrial aldehyde dehydrogenase inhibitor in mice.
    Staub RE; Quistad GB; Casida JE
    Chem Res Toxicol; 1998 May; 11(5):535-43. PubMed ID: 9585485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.
    Lamensdorf I; Eisenhofer G; Harvey-White J; Nechustan A; Kirk K; Kopin IJ
    Brain Res; 2000 Jun; 868(2):191-201. PubMed ID: 10854571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.
    Goldstein DS; Sullivan P; Holmes C; Miller GW; Alter S; Strong R; Mash DC; Kopin IJ; Sharabi Y
    J Neurochem; 2013 Sep; 126(5):591-603. PubMed ID: 23786406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction.
    Kao CY; Xu M; Wang L; Lin SC; Lee HJ; Duraine L; Bellen HJ; Goldstein DS; Tsai SY; Tsai MJ
    PLoS Genet; 2020 Jun; 16(6):e1008868. PubMed ID: 32579581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.
    Goldstein DS; Sullivan P; Holmes C; Kopin IJ; Sharabi Y; Mash DC
    Parkinsonism Relat Disord; 2015 Jun; 21(6):567-72. PubMed ID: 25829070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL).
    Follmer C; Coelho-Cerqueira E; Yatabe-Franco DY; Araujo GD; Pinheiro AS; Domont GB; Eliezer D
    J Biol Chem; 2015 Nov; 290(46):27660-79. PubMed ID: 26381411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease.
    Fitzmaurice AG; Rhodes SL; Cockburn M; Ritz B; Bronstein JM
    Neurology; 2014 Feb; 82(5):419-26. PubMed ID: 24491970
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Thamaraikani T; Karnam M; Velapandian C
    CNS Neurol Disord Drug Targets; 2022; 21(4):343-353. PubMed ID: 34477539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase inhibition generates a reactive dopamine metabolite autotoxic to dopamine neurons.
    Doorn JA; Florang VR; Schamp JH; Vanle BC
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1(0 1):S73-5. PubMed ID: 24262193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
    Wey MC; Fernandez E; Martinez PA; Sullivan P; Goldstein DS; Strong R
    PLoS One; 2012; 7(2):e31522. PubMed ID: 22384032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria.
    Kristal BS; Conway AD; Brown AM; Jain JC; Ulluci PA; Li SW; Burke WJ
    Free Radic Biol Med; 2001 Apr; 30(8):924-31. PubMed ID: 11295535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity.
    Vermeer LM; Florang VR; Doorn JA
    Brain Res; 2012 Sep; 1474():100-9. PubMed ID: 22877852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechols in post-mortem brain of patients with Parkinson disease.
    Goldstein DS; Sullivan P; Holmes C; Kopin IJ; Basile MJ; Mash DC
    Eur J Neurol; 2011 May; 18(5):703-10. PubMed ID: 21073636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldose reductase deficiency leads to oxidative stress-induced dopaminergic neuronal loss and autophagic abnormality in an animal model of Parkinson's disease.
    Yeung PKK; Lai AKW; Son HJ; Zhang X; Hwang O; Chung SSM; Chung SK
    Neurobiol Aging; 2017 Feb; 50():119-133. PubMed ID: 27960106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal.
    Florang VR; Rees JN; Brogden NK; Anderson DG; Hurley TD; Doorn JA
    Neurotoxicology; 2007 Jan; 28(1):76-82. PubMed ID: 16956664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde.
    Lamensdorf I; Eisenhofer G; Harvey-White J; Hayakawa Y; Kirk K; Kopin IJ
    J Neurosci Res; 2000 May; 60(4):552-8. PubMed ID: 10797558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.
    McCormack AL; Thiruchelvam M; Manning-Bog AB; Thiffault C; Langston JW; Cory-Slechta DA; Di Monte DA
    Neurobiol Dis; 2002 Jul; 10(2):119-27. PubMed ID: 12127150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.